Funding for this research was provided by:
A.P. Møller og Hustru Chastine Mc-Kinney Møllers Fond til almene Formaal
Novo Nordisk Investigator Initiated Studies
Received: 11 September 2020
Accepted: 24 December 2020
First Online: 7 January 2021
Ethics approval and consent to participate
: This study was approved by the Regional Committee on Biomedical Research Ethics of the Capital Region of Denmark and the Danish Medicines Agency. The study was carried out in accordance with the ICH-GCP (International Conference on Harmonization-Good Clinical Practice) standards. Written informed consent was obtained from each subject.
: All authors gave consent for publication.
: SBH has received funding of educational and research tasks from Novo Nordisk, Abbott, Eli Lilly, Pfizer, Boehringer-Ingelheim, Bristol-Meyers Squibb and Merck, Sharp & Dome. OWN has received funding of educational and research tasks from Resmed and participated in advisory boards for Novartis Pharma. PK, CA, OPK and AS have nothing to disclose.